0001104659-20-084577.txt : 20200717 0001104659-20-084577.hdr.sgml : 20200717 20200717172729 ACCESSION NUMBER: 0001104659-20-084577 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200715 FILED AS OF DATE: 20200717 DATE AS OF CHANGE: 20200717 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Blumenkranz Mark S. CENTRAL INDEX KEY: 0001614869 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36080 FILM NUMBER: 201034479 MAIL ADDRESS: STREET 1: C/O 1LIFE HEALTHCARE, INC. STREET 2: ONE EMBARCADERO CENTER, SUITE 1900 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IVERIC bio, Inc. CENTRAL INDEX KEY: 0001410939 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208185347 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE PENN PLAZA STREET 2: 35TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10119 BUSINESS PHONE: 212-845-8200 MAIL ADDRESS: STREET 1: ONE PENN PLAZA STREET 2: 35TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10119 FORMER COMPANY: FORMER CONFORMED NAME: Ophthotech Corp. DATE OF NAME CHANGE: 20070828 4 1 a4.xml 4 X0306 4 2020-07-15 0 0001410939 IVERIC bio, Inc. ISEE 0001614869 Blumenkranz Mark S. C/O IVERIC BIO, INC. ONE PENN PLAZA, 35TH FLOOR NEW YORK NY 10119 1 0 0 0 Stock Option (Right to Buy) 4.48 2020-07-15 4 A 0 31000 0 A 2030-07-14 Common Stock 31000 31000 D Restricted Stock Units 2020-07-15 4 A 0 15000 0 A Common Stock 15000 15000 D Subject to the Reporting Person providing continued services to the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the option will vest and become exercisable monthly with respect to 1/36th of the shares underlying such option until the third anniversary of the grant date. Each restricted stock unit represents the contingent right to receive one share of common stock of the Registrant upon vesting of the unit. Subject to the Reporting Person providing continued services to the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of the restricted stock units will vest annually with respect to 1/3rd of the shares underlying such award until the third anniversary of the grant date. /s/ Todd D.C. Anderman, as Attorney-in-Fact for Mark S. Blumenkranz 2020-07-17